Physician profile
Ameer Ali
NPI 1982065561
$5,801.96
in general payments reported to CMS, 2019-2025
21 companies · $1,632 in 2025
The $1,632 reported for 2025 was more than what 81% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $12.09 · 2021: $1,545 · 2022: $468 · 2023: $709 · 2024: $1,294 · 2025: $1,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,966 · Travel and Lodging: $1,423 · Education: $232 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,965.61 |
| Travel and Lodging | $1,423.34 |
| Education | $231.96 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,436.61 | 2021-2023 | Senza |
| Abbott Laboratories | $1,330.30 | 2022-2025 | Proclaim, Eterna, Infinity |
| Medtronic, INC. | $667.13 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Genesys Orthopedics Systems, L.L.C. | $412.50 | 2023 | Sacroiliac Joint Fusion System |
| Curonix LLC | $369.34 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $368.01 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Watchman Flx |
| Spinal Simplicity, LLC | $241.85 | 2022-2025 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $218.72 | 2022-2024 | Mild Device Kit |
| Stryker Corporation | $134.29 | 2022 | |
| Novo Nordisk INC | $124.99 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.95 | 2019 | |
| Collegium Pharmaceutical, INC. | $87.53 | 2024 | Belbuca |
| Vertex Pharmaceuticals Incorporated | $63.17 | 2024-2025 | |
| Allergan, INC. | $51.55 | 2022 | |
| Abbvie INC. | $48.45 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $39.65 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $37.82 | 2024 | |
| Nalu Medical, INC. | $16.90 | 2024 | Nalu Neurostimulation System |
| Alexion Pharmaceuticals, INC. | $16.11 | 2019 | |
| Spr Therapeutics, INC | $12.09 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ameer Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.